Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179413 · ClinicalTrials.gov registry record · Phase 4
Study of Long-term Peg Intron vs. Colchicine in Non-responders.
A Phase 4 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 549
- Enrollment target
NCT00179413: Completed Phase 4 study, sponsored by Beth Israel Deaconess Medical Center.
NCT00179413 is a Phase 4 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 549 participants, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00179413, a Phase 4 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 549 participants
- Enrollment target
Study Summary
In this study Peg-Intron will be tested to see if it will give better results than Colchicine. At this time, there is currently no recommended maintenance treatment for patients who have failed to respond to Interferon/Rebetron/Peg Intron and have advanced fibrosis. The purpose of this study is to compare two treatments to slow down the progression of liver disease and to prevent liver failure and liver cancer. The treatment will not cure Hepatitis C, but is being evaluated to see if it can slow down disease progression.
Primary Outcome
number of patients with a liver related outcomes including: mortality, liver transplant, variceal or portal hypertensive bleeding,Development of jaundice, ascites or encephalopathy with an increase in CPT of \> 2 points and development of hepatoma
Interventions
- DRUG Colchicine
- DRUG PEG -Intron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 549 participants |
| Start Date | 2000-01-15 |
| Est. Completion | 2010-03-03 |
| Phase | Phase 4 |
What the finished NCT00179413 record still lists
NCT00179413 is an interventional study that assigns participants to a tested intervention. The registered 549 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Colchicine is the first listed.
NCT00179413 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00179413 about?
NCT00179413 is a clinical study titled "Study of Long-term Peg Intron vs. Colchicine in Non-responders.". In this study Peg-Intron will be tested to see if it will give better results than Colchicine. At this time, there is currently no recommended maintenance treatment for patients who have failed to respond to Interferon/Rebetron/Peg Intron and have advanced fibrosis. The purpose of this study is to c...
What is the current status of trial NCT00179413?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 549 participants. The study started on 2000-01-15. Estimated completion is 2010-03-03.
What interventions are being tested in trial NCT00179413?
The interventions under investigation include: Colchicine (DRUG), PEG -Intron (DRUG).
Who is sponsoring clinical trial NCT00179413?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00179413's enrollment target sits among peer trials
549 153rd of 2000 higher than 1,848 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI